If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Use in Patients With T1DM
Tirzepatide has not been studied in people with type 1 diabetes.
cFAQ
cFAQ
US_cFAQ_TZP052_USE_T1DM
en-US
Detailed Information
There is no information on the use of tirzepatide in people with T1DM because patients with T1DM were excluded from tirzepatide clinical trials. At this time, we do not have plans to conduct tirzepatide clinical trials in people with T1DM.
Glossary
T1DM = type 1 diabetes mellitus
Date of Last Review: March 02, 2021
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays